MARINA
Live / Registered — Registered (as of 24 Oct 2023)
What this means for you
Registered since 24 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97087685
- Registration number
- 7202824
- Mark type
- Stylized text
- Filed
- 22 Oct 2021
- Published for opposition
- 28 Jun 2022
- Registered
- 24 Oct 2023
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Avidity Biosciences, Inc., San Diego, CA, US
- Avidity Biosciences, Inc., San Diego, CA, US
- Avidity Biosciences, Inc., San Diego, CA, US
Prosecution history
- 05 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Sept 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Sept 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 22 Sept 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Sept 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE